NCT06380569 A Strength-Based Intervention to Improve Job Interview Skills in Young Adults in a Community Setting
| NCT ID | NCT06380569 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Kessler Foundation |
| Condition | Autism Spectrum Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2024-07-01 |
| Primary Completion | 2025-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2024-07-01 with a primary completion date of 2025-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The investigators are looking to evaluate how effective a strength-based intervention may be in improving job interview skills in young adults. The investigators are examining the effects of this intervention in young adults who may have difficulty with job interviews, and who may want to improve these skills.
Eligibility Criteria
Inclusion Criteria: Lives in the United States of America Between the ages of 14-26 Speaks English well and at a 4th grade reading level Exclusion Criteria: Had a stroke, Traumatic Brain Injury, or neurological injury or disease in the past(like brain tumor or epilepsy) Has a history of significant psychiatric illness(like schizophrenia or psychosis) Has uncontrolled seizures or other unstable medical complications
Contact & Investigator
Helen Genova, Ph. D.
PRINCIPAL INVESTIGATOR
Kessler Foundation
Frequently Asked Questions
Who can join the NCT06380569 clinical trial?
This trial is open to participants of all sexes, aged 14 Years or older, up to 26 Years, studying Autism Spectrum Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06380569 currently recruiting?
Yes, NCT06380569 is actively recruiting participants. Contact the research team at hgenova@kesslerfoundation.org for enrollment information.
Where is the NCT06380569 trial being conducted?
This trial is being conducted at East Hanover, United States.
Who is sponsoring the NCT06380569 clinical trial?
NCT06380569 is sponsored by Kessler Foundation. The principal investigator is Helen Genova, Ph. D. at Kessler Foundation. The trial plans to enroll 30 participants.